Skip to main content
NCBI home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 2001 Mar-Apr;7(2):312–318. doi: 10.3201/eid0702.010234

Molecular approaches to diagnosing and managing infectious diseases: practicality and costs.

M A Pfaller 1
PMCID: PMC2631730  PMID: 11294731

Abstract

As molecular techniques for identifying and detecting microorganisms in the clinical microbiology laboratory have become routine, questions about the cost of these techniques and their contribution to patient care need to be addressed. Molecular diagnosis is most appropriate for infectious agents that are difficult to detect, identify, or test for susceptibility in a timely fashion with conventional methods.

Full Text

The Full Text of this article is available as a PDF (98.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anthony R. M., Brown T. J., French G. L. Rapid diagnosis of bacteremia by universal amplification of 23S ribosomal DNA followed by hybridization to an oligonucleotide array. J Clin Microbiol. 2000 Feb;38(2):781–788. doi: 10.1128/jcm.38.2.781-788.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Back N. A., Linnemann C. C., Jr, Pfaller M. A., Staneck J. L., Morthland V. Recurrent epidemics caused by a single strain of erythromycin-resistant Staphylococcus aureus. The importance of molecular epidemiology. JAMA. 1993 Sep 15;270(11):1329–1333. [PubMed] [Google Scholar]
  3. Bergeron M. G., Ouellette M. Preventing antibiotic resistance using rapid DNA-based diagnostic tests. Infect Control Hosp Epidemiol. 1998 Aug;19(8):560–564. doi: 10.1086/647873. [DOI] [PubMed] [Google Scholar]
  4. Cockerill F. R., 3rd Genetic methods for assessing antimicrobial resistance. Antimicrob Agents Chemother. 1999 Feb;43(2):199–212. doi: 10.1128/aac.43.2.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Courvalin P. Genotypic approach to the study of bacterial resistance to antibiotics. Antimicrob Agents Chemother. 1991 Jun;35(6):1019–1023. doi: 10.1128/aac.35.6.1019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ferreira-Gonzalez A., Garrett C. T. Pitfalls in establishing a molecular diagnostic laboratory. Hum Pathol. 1996 May;27(5):437–440. doi: 10.1016/s0046-8177(96)90087-8. [DOI] [PubMed] [Google Scholar]
  7. Fredricks D. N., Relman D. A. Application of polymerase chain reaction to the diagnosis of infectious diseases. Clin Infect Dis. 1999 Sep;29(3):475–488. doi: 10.1086/598618. [DOI] [PubMed] [Google Scholar]
  8. Fredricks D. N., Relman D. A. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin Microbiol Rev. 1996 Jan;9(1):18–33. doi: 10.1128/cmr.9.1.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hacek D. M., Suriano T., Noskin G. A., Kruszynski J., Reisberg B., Peterson L. R. Medical and economic benefit of a comprehensive infection control program that includes routine determination of microbial clonality. Am J Clin Pathol. 1999 May;111(5):647–654. doi: 10.1093/ajcp/111.5.647. [DOI] [PubMed] [Google Scholar]
  10. Hecht F. M., Grant R. M., Petropoulos C. J., Dillon B., Chesney M. A., Tian H., Hellmann N. S., Bandrapalli N. I., Digilio L., Branson B. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. N Engl J Med. 1998 Jul 30;339(5):307–311. doi: 10.1056/NEJM199807303390504. [DOI] [PubMed] [Google Scholar]
  11. Hussain Z., Stoakes L., Massey V., Diagre D., Fitzgerald V., El Sayed S., Lannigan R. Correlation of oxacillin MIC with mecA gene carriage in coagulase-negative staphylococci. J Clin Microbiol. 2000 Feb;38(2):752–754. doi: 10.1128/jcm.38.2.752-754.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kant J. A. Molecular diagnostics. Reimbursement and other selected financial issues. Diagn Mol Pathol. 1995 Jun;4(2):79–81. doi: 10.1097/00019606-199506000-00001. [DOI] [PubMed] [Google Scholar]
  13. Marshall S. A., Wilke W. W., Pfaller M. A., Jones R. N. Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections: frequency of occurrence, antimicrobial susceptibility, and molecular (mecA) characterization of oxacillin resistance in the SCOPE program. Diagn Microbiol Infect Dis. 1998 Mar;30(3):205–214. doi: 10.1016/s0732-8893(97)00212-5. [DOI] [PubMed] [Google Scholar]
  14. Nolte F. S. Impact of viral load testing on patient care. Arch Pathol Lab Med. 1999 Nov;123(11):1011–1014. doi: 10.5858/1999-123-1011-IOVLTO. [DOI] [PubMed] [Google Scholar]
  15. Pfaller M. A., Herwaldt L. A. The clinical microbiology laboratory and infection control: emerging pathogens, antimicrobial resistance, and new technology. Clin Infect Dis. 1997 Oct;25(4):858–870. doi: 10.1086/515557. [DOI] [PubMed] [Google Scholar]
  16. Pfaller M. A. Molecular epidemiology in the care of patients. Arch Pathol Lab Med. 1999 Nov;123(11):1007–1010. doi: 10.5858/1999-123-1007-MEITCO. [DOI] [PubMed] [Google Scholar]
  17. Ross J. S. Financial determinants of outcomes in molecular testing. Arch Pathol Lab Med. 1999 Nov;123(11):1071–1075. doi: 10.5858/1999-123-1071-FDOOIM. [DOI] [PubMed] [Google Scholar]
  18. Stuyver L., Van Geyt C., De Gendt S., Van Reybroeck G., Zoulim F., Leroux-Roels G., Rossau R. Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy. J Clin Microbiol. 2000 Feb;38(2):702–707. doi: 10.1128/jcm.38.2.702-707.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Woods G. L. Molecular techniques in mycobacterial detection. Arch Pathol Lab Med. 2001 Jan;125(1):122–126. doi: 10.5858/2001-125-0122-MTIMD. [DOI] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES